Last reviewed · How we verify

NCT07072442

Integrative Chinese and Western Medicine for Knee Osteoarthritis

Not yet recruiting NA Last updated 18 July 2025
What this trial tests

NA trial testing Western Medicine in Knee Osteoarthristis in 228 participants. Not yet recruiting.

Timeline
1 August 2025
Primary endpoint
30 June 2028
31 July 2028

Quick facts

Lead sponsorChang Gung Memorial Hospital
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationnon randomized
Designfactorial
Maskingnone
Primary purposetreatment
Enrollment228
Start date1 August 2025
Primary completion30 June 2028
Estimated completion31 July 2028

Drugs / interventions tested

Conditions studied

Sponsor

Chang Gung Memorial Hospital

Who can join

18 and older, any sex, with Knee Osteoarthristis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to investigate if an integrated approach combining Traditional Chinese and Western medicine can better treat knee osteoarthritis. The goal is to see if this combined therapy can more effectively reduce pain severity and frequency, leading to an improved quality of life for KOA patients. Additionally, the study will explore the underlying mechanisms of pain and anti-inflammation related to KOA.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Western Medicine

Trials testing the same drug.

Other recruiting trials for Knee Osteoarthristis

Currently open trials in the same condition.

Other Chang Gung Memorial Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07072442.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing